Patent US3816921A successfully refreshed from Google Patents.
US4800159A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for amplifying, detecting, and/or cloning nucleic acid sequences
Assignee: Roche Molecular Systems Inc
•
Filing: 1986-12-17
•
Granted: 1989-01-24
•
Expires: 2006-12-17
Abstract
Abstract The present invention is directed to a process for amplifying and detecting any target nucleic acid sequence contained in a nucleic acid or mixture thereof. The process comprises treating separate complementary strands of the nucleic acid with a molar excess of two oligonucleotide primers, extending the primers to form complementary primer extension products which act as templates for synthesizing the desired nucleic acid sequence, and detecting the sequence so amplified. The steps of the reaction may be carried out stepwise or simultaneously and can be repeated as often as desired. In addition, a specific nucleic acid sequence may be cloned into a vector by using primers to amplify the sequence, which contain restriction sites on their non-complementary ends, and a nucleic acid fragment may be prepared from an existing shorter fragment using the amplification process.
Inventors
- 👤 Kary B. Mullis
- 👤 Henry A. Erlich
- 👤 Norman Arnheim
- 👤 Glenn T. Horn
- 👤 Randall K. Saiki
- 👤 Stephen J. Scharf
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 14:06
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6844; C12Q1/6858
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
268 words
A process for cloning into a vector a specific nucleic acid sequence contained in a nucleic acid or a mixture of nucleic acids, which process comprises: a. treating the nucleic acid(s) with one oligonucleotide primer for each strand of each different specific sequence being amplified, under conditions such that for each strand of each different sequence being amplified an extension product of wherein said primer or primers are selected so as to be sufficiently complementary to each strand of each specific sequence to hybridize therewith such that the extension product synthesized from one primer, when it is separated from its complement, can serve as a template for synthesis of the extension product of the other primer, and wherein said primer or primers each contain a restriction site on its 5' end which is the same as or different from the restriction site(s) on the other primer(s); b. separating the primer extension products from the templates on which they were synthesized to produce single-stranded molecules; c. treating the single-stranded molecules generated from step (b) with oligonucleotide primers such that a primer extension product is synthesized using each of the single strands produced in step (b) as a template, wherein depending on the particular sequence being amplified, steps (a) and (c) are carried out in the presence of from 0 to 10% dimethylsulfoxide or at a temperature of 35° C. to 45° C. d. adding to the product of step (c) a restriction enzyme for each of said restriction sites to obtain cleaved products in a restriction digest; and e. ligating the cleaved product(s) into one or more cloning vectors.
Claim 2
Dependent Claim
268 words
A process for cloning into a vector a specific nucleic acid sequence contained in a nucleic acid or a mixture of nucleic acids, which process comprises: a. treating the nucleic acid(s) with one oligonucleotide primer for each strand of each different specific sequence being amplified, under conditions such that for each strand of each different sequence being amplified an extension product of wherein said primer or primers are selected so as to be sufficiently complementary to each strand of each specific sequence to hybridize therewith such that the extension product synthesized from one primer, when it is separated from its complement, can serve as a template for synthesis of the extension product of the other primer, and wherein said primer or primers each contain a restriction site on its 5' end which is the same as or different from the restriction site(s) on the other primer(s); b. separating the primer extension products from the templates on which they were synthesized to produce single-stranded molecules; c. treating the single-stranded molecules generated from step (b) with oligonucleotide primers such that a primer extension product is synthesized using each of the single strands produced in step (b) as a template, wherein depending on the particular sequence being amplified, steps (a) and (c) are carried out in the presence of from 0 to 10% dimethylsulfoxide or at a temperature of 35° C. to 45° C. d. adding to the product of step (c) a restriction enzyme for each of said restriction sites to obtain cleaved products in a restriction digest; and e. ligating the cleaved product(s) into one or more cloning vectors.
Claim 3
Dependent Claim
24 words
The process of claim 1, further comprising the step of passing the restriction digest of step (d) through a desalting column before step (e).
Claim 4
Dependent Claim
16 words
The process of claim 1, further comprising, after step (e), sequencing the specific nucleic acid sequence.
Claim 5
Dependent Claim
20 words
The process of claim 1, further comprising, after step (e), expressing the protein encoded by the specific nuclei acid sequence.
Claim 6
Dependent Claim
35 words
The process of claim 1, wherein one sequence is being amplified, the restriction sites are different on each primer, and the product of step (d) is ligated into a cloning vector with a specific orientation.
Claim 7
Dependent Claim
25 words
The process of claim 1, wherein the specific nucleic acid sequence being amplified is or is contained within the β-globin gene or the N-RAS oncogene.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-01-24 | 1992-07-25 | 1993-01-24 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-01-24 | 1996-07-25 | 1997-01-24 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-01-24 | 2000-07-25 | 2001-01-24 | $7700.00 | Window Closed / Lapsed |